342 related articles for article (PubMed ID: 30809937)
1. Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1α/Notch1 axis.
Zhang HS; Zhang ZG; Du GY; Sun HL; Liu HY; Zhou Z; Gou XM; Wu XH; Yu XY; Huang YH
J Cell Mol Med; 2019 May; 23(5):3451-3463. PubMed ID: 30809937
[TBL] [Abstract][Full Text] [Related]
2. miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism.
Mahajan M; Sitasawad S
Cells; 2021 Dec; 11(1):. PubMed ID: 35011574
[TBL] [Abstract][Full Text] [Related]
3. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
4. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
5. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
[TBL] [Abstract][Full Text] [Related]
6. UBXN7 cofactor of CRL3
Di Gregorio J; Cilenti L; Ambivero CT; Andl T; Liao R; Zervos AS
Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(4):118963. PubMed ID: 33444648
[TBL] [Abstract][Full Text] [Related]
7. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
Kamble D; Mahajan M; Dhat R; Sitasawad S
Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the ERK/HIF-1α/EMT Pathway in XCL1-Induced Migration of MDA-MB-231 and SK-BR-3 Breast Cancer Cells.
Do HTT; Cho J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374849
[TBL] [Abstract][Full Text] [Related]
9. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.
Zhang HS; Du GY; Zhang ZG; Zhou Z; Sun HL; Yu XY; Shi YT; Xiong DN; Li H; Huang YH
Int J Biochem Cell Biol; 2018 Feb; 95():85-92. PubMed ID: 29275212
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia Promotes Pancreatic Cancer Cell Dedifferentiation to Stem-Like Cell Phenotypes With High Tumorigenic Potential by the HIF-1α/Notch Signaling Pathway.
Mu R; Zou YK; Tu K; Wang DB; Tang D; Yu Z; Zhao L
Pancreas; 2021 May-Jun 01; 50(5):756-765. PubMed ID: 34016895
[TBL] [Abstract][Full Text] [Related]
11. Sequestosome 1 (p62) mitigates hypoxia-induced cardiac dysfunction by stabilizing hypoxia-inducible factor 1α and nuclear factor erythroid 2-related factor 2.
Ghosh R; Fatahian AN; Rouzbehani OMT; Hathaway MA; Mosleh T; Vinod V; Vowles S; Stephens SL; Chung SD; Cao ID; Jonnavithula A; Symons JD; Boudina S
Cardiovasc Res; 2024 Apr; 120(5):531-547. PubMed ID: 38332738
[TBL] [Abstract][Full Text] [Related]
12. The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway.
Takamiya R; Takahashi M; Uehara Y; Ariki S; Hashimoto J; Hasegawa Y; Kuroki Y
Biochem Biophys Res Commun; 2014 Nov; 454(3):364-8. PubMed ID: 25451255
[TBL] [Abstract][Full Text] [Related]
13. Notch1-Nrf2 signaling crosstalk provides myocardial protection by reducing ROS formation.
Zhou XL; Wu X; Zhu RR; Xu H; Li YY; Xu QR; Liu S; Lai SQ; Xu X; Wan L; Wu QC; Liu JC
Biochem Cell Biol; 2020 Apr; 98(2):106-111. PubMed ID: 32069075
[TBL] [Abstract][Full Text] [Related]
14. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
15. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
16. Antioral Squamous Cell Carcinoma Effects of Carvacrol via Inhibiting Inflammation, Proliferation, and Migration Related to Nrf2/Keap1 Pathway.
Liu H; Xu X; Wu R; Bi L; Zhang C; Chen H; Yang Y
Biomed Res Int; 2021; 2021():6616547. PubMed ID: 34212035
[TBL] [Abstract][Full Text] [Related]
17. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative Activity of Ursolic Acid in MDA-MB-231 Human Breast Cancer Cells through Nrf2 Pathway Regulation.
Zhang X; Li T; Gong ES; Liu RH
J Agric Food Chem; 2020 Jul; 68(28):7404-7415. PubMed ID: 32551573
[TBL] [Abstract][Full Text] [Related]
19. Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism.
Chartoumpekis DV; Wakabayashi N; Kensler TW
Biochem Soc Trans; 2015 Aug; 43(4):639-44. PubMed ID: 26551705
[TBL] [Abstract][Full Text] [Related]
20. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
